Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2003
03/19/2003CN1403479A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403478A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403477A Human protein with function of promoting 3T3 cell conversion and its coding sequence
03/19/2003CN1403476A Human protein with function of promoting 3T3 cell conversion and its coding sequence
03/19/2003CN1403475A Human protein with cancer suppressing function and its coding sequence
03/18/2003US6534643 Isolated nucleic acid of given sequence; useful for homology-dependent pairing of three DNA strands; use in cloning and gene mapping
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534485 Novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein.
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534313 A recombinant vector comprising polynucleotide sequence whose overexpression results in a dwarf phenotype; cytochrome; insect resistance and darker-green foliage
03/18/2003US6534300 Methods for producing highly phosphorylated lysosomal hydrolases
03/18/2003US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects
03/18/2003US6534290 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
03/18/2003US6534280 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
03/18/2003US6534277 Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins
03/18/2003US6534276 Methods for detecting human tissue factor inhibitor
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534066 Inactivated vaccine against feline calicivirosis
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534060 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
03/18/2003US6534059 Administering to the eye of said mammal a composition comprising antibody to interferon gamma.
03/18/2003US6534058 Anti-C5 monoclonal antibodies
03/18/2003US6534057 Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
03/18/2003US6534055 Methods for selectively stimulating proliferation of T cells
03/18/2003US6534051 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003CA2121370C Specific tolerance in transplantation
03/18/2003CA2040412C Brain derived neurotrophic factor
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
03/17/2003WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021226A2 Peptide biomarker and method of identification
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020909A2 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
03/13/2003WO2003020875A2 Staphylococci surface-exposed immunogenic polypeptides
03/13/2003WO2003020769A1 Pemphigus monoclonal antibody
03/13/2003WO2003020768A1 A method for the treatment or prevention of bone erosion
03/13/2003WO2003020767A2 Antibodies against caspase-8, their preparation and use
03/13/2003WO2003020765A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020757A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020215A2 Methods of treating mycocardial event related coditions with thymosin beta 4
03/13/2003WO2003020212A2 Treatment for central nervous system disorders
03/13/2003WO2003020111A2 Alternatively spliced circulating tissue factor
03/13/2003WO2003020013A1 Plant-derived resistance gene
03/13/2003WO2003000176A3 Conjugates of reduced antibodies and biomolecules
03/13/2003WO2002081653A3 An animal model for enteric pathogens
03/13/2003WO2002079377A3 Antibodies that immunospecifically bind to trail receptors
03/13/2003WO2002078742A3 Methods and compositions for treatment of immune dysfunction disorders
03/13/2003WO2002077213A3 New elongase gene and production of δ9-polyunsaturated fatty acids
03/13/2003WO2002075275A3 Polyclonal populations of bispecific molecules and methods of production and uses thereof
03/13/2003WO2002067760A3 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/13/2003WO2002066059A8 Agents that specifically block cd28-mediated signaling and uses therefor
03/13/2003WO2002064629A3 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
03/13/2003WO2002063012A3 Ragweed allergens
03/13/2003WO2002062832A3 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity
03/13/2003WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/13/2003WO2002048675A3 Improved compositions and methods for producing antibodies to low molecular weight analytes
03/13/2003WO2002048363A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/13/2003WO2002046407A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002044380A3 Master bone formation transcription factor: compositions and methods of use
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002044364A3 Polypeptides involved in immune response
03/13/2003WO2002042456A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002034290A3 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma
03/13/2003WO2002034288A3 Vaccine for treating allergy
03/13/2003WO2002032936A3 E. histolytica-specific antibodies and clinical uses thereof
03/13/2003WO2002030986A3 HUMANIZED ANTI-LT-β-R ANTIBODIES
03/13/2003WO2002030460A3 Therapeutic antibodies
03/13/2003WO2002026983A3 56115, a novel human twik potassium channel and uses therefor
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2002024920A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/13/2003WO2002020757A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002020056A3 Methods and compositions for producing a neurosalutary effect in a subject
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002016416A3 Diagnosis and treatment of cardiovascular conditions
03/13/2003WO2002012272A8 Therapeutic anti-melanoma compounds
03/13/2003WO2002011762A3 Methods and compositions for modulating tumor growth
03/13/2003WO2002008284A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002006340A3 Tetraspan protein and uses thereof
03/13/2003WO2002002635A3 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
03/13/2003WO2002000690A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2001096376A3 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
03/13/2003WO2001085946A3 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003US20030050466 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer or autoimmune diaseses
03/13/2003US20030050465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050459 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
03/13/2003US20030050457 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050450 Dissociation of immunoglobulin containing biopolymer column; obtain sample containing immunoglobulin, incubate with chromatographic column, adjust hydrogen ion concentration, recover immunoglobulin segment
03/13/2003US20030050449 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
1 ... 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 ... 1494